FoxFeed Blog

The latest reporting and analysis on breakthroughs in Parkinson's research and issues that matter most to you.

Poetry Contest Calls for Pieces Related to Health

March 31, 2015

The poetically inclined can share their experiences with Health Affairs for a chance to be published in the journal.

More Medication but Fewer Side Effects

March 29, 2015

Rytary, an extended-release formuation of levodopa/carbidopa, will soon be available for prescription. The treatment requires more pills but comes with less dyskinesia.

video thumbnail

Crossfit Community Supports Member with Parkinson's

March 26, 2015

Peter Marconi found both Crossfit and the New England Parkinson's Ride as ways to stay active after being diagnosed with Parkinson's in 2012.

Join the 21st Parkinson's Unity Walk on April 25

March 25, 2015

Ken Aidekman, Co-founder of the Parkinson's Unity Walk reflects on the walk's growth over the last 21 years as we look forward to this year's event which is taking place on Sat., April 25 in NYC.

Q-and-A with 23andMe Parkinson's Community Lead

March 25, 2015

Paul Cannon, PhD, who leads the 23andMe Parkinson's Community, spoke with MJFF about the company's recent news and what it means for Parkinson's disease drug development.

PPMI Now Recruiting Individuals with Genetic Mutation linked to Gaucher Disease

March 24, 2015

The Parkinson's Progression Markers Initiative (PPMI), a large-scale biomarker study sponsored by The Michael J. Fox Foundation (MJFF) is expanding to study individuals with a genetic mutation of the

Alzheimer's Drug Shows Promise in Slowing Disease

March 23, 2015

Pharmaceutical company Biogen last week shared positive results from its study of a drug to slow Alzheimer's progression. These findings have implications for Parkinson's research, as well.

The White House Honors Parkinson's Champions

March 23, 2015

On Monday, March 23, The White House honors MJFF co-founder and executive vice chairman Debi Brooks and Patient Council member Steve DeWitte among nine Champions of Change for Parkinson's patients.

Second Parkinson's Vaccine Reports Positive Safety Results

March 20, 2015

Irish biotechnology company Prothena announced yesterday that its vaccine in development to slow Parkinson's disease (PD) progression was safe and tolerable in a Phase I study.